Document Detail


Infliximab treatment of sarcoidosis.
MedLine Citation:
PMID:  12659618     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine whether there is sufficient evidence in the literature to support the use of infliximab in the treatment of sarcoidosis. DATA SOURCES AND SELECTION: Literature was accessed through MEDLINE (1966-August 2002), OVID (2001-January 2003), and bibliographic searches. Additional databases were also searched. Published literature relevant to the use of infliximab in the treatment of sarcoidosis was evaluated. DATA SYNTHESIS: In theory, tumor-necrosis factor-alpha blockade appears to be an optimal strategy for treating sarcoidosis. Case series reporting the use of infliximab in refractory sarcoidosis was reviewed to evaluate its potential role as a treatment option. CONCLUSIONS: Although there is insufficient evidence suggesting that infliximab is an appropriate alternative to conventional treatment options as first-line therapy for sarcoidosis, the preliminary outlook on its use in treatment-refractory cases is promising.
Authors:
Ryan N Serio
Related Documents :
15517448 - Kikuchi-fujimoto's disease associated with systemic lupus erythematosus: case report an...
20601838 - Systemic lupus erythematosus complicated by recurrent pneumothorax: case report and lit...
904398 - Problems of diagnosis in the evaluation of mediastinal sarcoidosis.
6420448 - A circulating lupus-like coagulation inhibitor induced by chlorpromazine.
12945598 - Noma (cancrum oris) associated with oral myiasis in an adult.
12717458 - A review of 101 homicide cases in jos, nigeria.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  37     ISSN:  1060-0280     ISO Abbreviation:  Ann Pharmacother     Publication Date:  2003 Apr 
Date Detail:
Created Date:  2003-03-27     Completed Date:  2003-07-01     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  577-81     Citation Subset:  IM    
Affiliation:
St. John's University, 164-40 95 St., Howard Beach, NY 11414-3704, USA. condram@msn.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / adverse effects,  pharmacology,  therapeutic use*
Humans
Sarcoidosis / drug therapy*,  physiopathology
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/infliximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thalidomide dosing in patients with relapsed or refractory multiple myeloma.
Next Document:  Testosterone replacement therapy for bone loss prevention in HIV-infected males.